SIMILAR PATTERNS OF AMINO ACIDS FOR 4URN_A_NOVA2000
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1aj6 | GYRASE (Escherichiacoli) |
PF02518(HATPase_c) | 7 | ASN A 46GLU A 50ASP A 73ARG A 76PRO A 79ILE A 94THR A 165 | NOV A 1 (-4.0A)NOV A 1 (-3.8A)NOV A 1 (-3.5A)NOV A 1 (-3.5A)NOV A 1 (-4.2A)NOV A 1 ( 4.4A)NOV A 1 ( 4.1A) | 0.66A | 4urnA-1aj6A:29.1 | 4urnA-1aj6A:52.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1b63 | MUTL (Escherichiacoli) |
PF01119(DNA_mis_repair)PF13589(HATPase_c_3) | 5 | ASN A 33SER A 34ASP A 36ASP A 58THR A 143 | MG A 701 ( 2.5A)ANP A 380 ( 3.8A)NoneANP A 380 (-3.6A)ANP A 380 (-3.7A) | 0.26A | 4urnA-1b63A:14.3 | 4urnA-1b63A:22.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ea6 | PMS1 PROTEIN HOMOLOG2 (Homo sapiens) |
PF01119(DNA_mis_repair)PF13589(HATPase_c_3) | 5 | ASN A 45SER A 46ASP A 48ASP A 70THR A 155 | MG A1365 ( 3.0A)ADP A1366 ( 3.9A)NoneADP A1366 (-3.4A)ADP A1366 ( 4.0A) | 0.44A | 4urnA-1ea6A:15.4 | 4urnA-1ea6A:20.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1gri | GROWTH FACTOR BOUNDPROTEIN 2 (Homo sapiens) |
PF00017(SH2)PF00018(SH3_1) | 5 | SER A 75ASP A 104GLU A 71ARG A 67ARG A 86 | None | 1.34A | 4urnA-1griA:undetectable | 4urnA-1griA:20.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1kij | DNA GYRASE SUBUNIT B (Thermusthermophilus) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 9 | ASN A 45ASP A 48GLU A 49ASP A 72ARG A 75PRO A 78ILE A 93ARG A 135THR A 166 | NOV A 400 (-3.8A)NOV A 400 (-4.5A)NOV A 400 (-3.6A)NOV A 400 (-3.1A)NOV A 400 (-3.4A)NOV A 400 (-4.4A)NOV A 400 (-4.5A)NOV A 400 (-2.7A)NOV A 400 (-3.3A) | 0.85A | 4urnA-1kijA:27.9 | 4urnA-1kijA:32.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1s14 | TOPOISOMERASE IVSUBUNIT B (Escherichiacoli) |
PF02518(HATPase_c) | 11 | ASN A1042SER A1043ASP A1045GLU A1046ASP A1069ARG A1072MET A1074PRO A1075ILE A1090ARG A1132THR A1163 | NOV A1300 (-3.7A)NOV A1300 (-3.6A)NoneNOV A1300 (-3.7A)NOV A1300 (-3.4A)NOV A1300 (-3.1A)NOV A1300 (-3.7A)NOV A1300 (-4.5A)NOV A1300 ( 4.6A)NOV A1300 (-2.9A)NOV A1300 ( 4.0A) | 0.79A | 4urnA-1s14A:24.9 | 4urnA-1s14A:38.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1s16 | TOPOISOMERASE IVSUBUNIT B (Escherichiacoli) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 9 | ASN A1042SER A1043ASP A1045GLU A1046ASP A1069ARG A1072MET A1074ILE A1090THR A1163 | ANP A1500 (-3.2A)ANP A1500 ( 4.0A)NoneANP A1500 (-3.7A)ANP A1500 (-3.5A)NoneANP A1500 (-4.3A)ANP A1500 ( 3.2A)ANP A1500 (-3.7A) | 0.97A | 4urnA-1s16A:25.0 | 4urnA-1s16A:30.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1s16 | TOPOISOMERASE IVSUBUNIT B (Escherichiacoli) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 10 | ASN A1042SER A1043ASP A1045GLU A1046ASP A1069ARG A1072MET A1074PRO A1075ARG A1132THR A1163 | ANP A1500 (-3.2A)ANP A1500 ( 4.0A)NoneANP A1500 (-3.7A)ANP A1500 (-3.5A)NoneANP A1500 (-4.3A)NoneNoneANP A1500 (-3.7A) | 0.83A | 4urnA-1s16A:25.0 | 4urnA-1s16A:30.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1s16 | TOPOISOMERASE IVSUBUNIT B (Escherichiacoli) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 6 | ASP A1045GLU A1046ARG A1072MET A1074ILE A1116THR A1163 | NoneANP A1500 (-3.7A)NoneANP A1500 (-4.3A)ANP A1500 (-4.1A)ANP A1500 (-3.7A) | 1.37A | 4urnA-1s16A:25.0 | 4urnA-1s16A:30.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1t6s | CONSERVEDHYPOTHETICAL PROTEIN (Chlorobaculumtepidum) |
PF04079(SMC_ScpB) | 5 | ASN A 49ASP A 46GLU A 47ASP A 51ARG A 5 | NoneNO3 A 407 ( 4.9A)NoneNoneNone | 1.14A | 4urnA-1t6sA:undetectable | 4urnA-1t6sA:19.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1t6s | CONSERVEDHYPOTHETICAL PROTEIN (Chlorobaculumtepidum) |
PF04079(SMC_ScpB) | 5 | ASP A 46GLU A 47ASP A 51ARG A 5ILE A 16 | NO3 A 407 ( 4.9A)NoneNoneNoneNone | 1.17A | 4urnA-1t6sA:undetectable | 4urnA-1t6sA:19.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1v2d | GLUTAMINEAMINOTRANSFERASE (Thermusthermophilus) |
PF00155(Aminotran_1_2) | 5 | ASN A 159ASP A 191GLU A 192ARG A 205PRO A 203 | PLP A 510 (-3.3A)PLP A 510 (-2.7A)NoneNoneNone | 1.46A | 4urnA-1v2dA:undetectable | 4urnA-1v2dA:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wac | P2 PROTEIN (Pseudomonasvirus phi6) |
PF00680(RdRP_1) | 5 | ASP A 453ASP A 327PRO A 333ARG A 109THR A 330 | None | 1.43A | 4urnA-1wacA:undetectable | 4urnA-1wacA:18.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1z5a | TYPE II DNATOPOISOMERASE VISUBUNIT B (Sulfolobusshibatae) |
PF02518(HATPase_c)PF05833(FbpA)PF09239(Topo-VIb_trans) | 5 | ASN A 42SER A 43ASP A 45ASP A 76THR A 170 | MG A1001 ( 2.6A)ADP A2001 ( 3.9A)NoneADP A2001 (-3.7A)ADP A2001 ( 3.9A) | 0.32A | 4urnA-1z5aA:17.5 | 4urnA-1z5aA:18.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2iop | CHAPERONE PROTEINHTPG (Escherichiacoli) |
PF00183(HSP90)PF02518(HATPase_c) | 5 | ASN A 38ASP A 41ASP A 80MET A 85THR A 174 | ADP A1001 (-3.9A)NoneADP A1001 (-3.9A)ADP A1001 (-3.7A)ADP A1001 (-3.4A) | 0.64A | 4urnA-2iopA:11.4 | 4urnA-2iopA:15.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2jh3 | RIBOSOMAL PROTEINS2-RELATED PROTEIN (Deinococcusradiodurans) |
PF01903(CbiX) | 5 | SER A 73GLU A 74ARG A 112PRO A 93THR A 78 | None | 1.38A | 4urnA-2jh3A:undetectable | 4urnA-2jh3A:17.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2muo | SECRETEDLY-6/UPAR-RELATEDPROTEIN 1 (Homo sapiens) |
PF00021(UPAR_LY6) | 5 | SER A 153ASP A 125MET A 129ILE A 169ARG A 149 | None | 1.41A | 4urnA-2muoA:undetectable | 4urnA-2muoA:14.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2nn6 | POLYMYOSITIS/SCLERODERMA AUTOANTIGEN 1 (Homo sapiens) |
PF01138(RNase_PH)PF03725(RNase_PH_C) | 5 | ASN A 144GLU A 211ASP A 142ILE A 146THR A 53 | None | 1.41A | 4urnA-2nn6A:undetectable | 4urnA-2nn6A:16.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pq0 | HYPOTHETICALCONSERVED PROTEINGK1056 (Geobacilluskaustophilus) |
PF08282(Hydrolase_3) | 5 | SER A 112ASP A 134ILE A 143ARG A 88THR A 91 | None | 1.35A | 4urnA-2pq0A:undetectable | 4urnA-2pq0A:20.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xcm | CYTOSOLIC HEAT SHOCKPROTEIN 90 (Hordeum vulgare) |
PF00183(HSP90)PF02518(HATPase_c) | 5 | ASN A 39SER A 40ASP A 42ASP A 81THR A 173 | ADP A1211 ( 2.6A)ADP A1211 ( 4.0A)NoneADP A1211 (-3.5A)ADP A1211 (-3.4A) | 0.34A | 4urnA-2xcmA:11.9 | 4urnA-2xcmA:23.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xcm | CYTOSOLIC HEAT SHOCKPROTEIN 90 (Hordeum vulgare) |
PF00183(HSP90)PF02518(HATPase_c) | 5 | SER A 40ASP A 42ASP A 81MET A 86THR A 173 | ADP A1211 ( 4.0A)NoneADP A1211 (-3.5A)ADP A1211 (-3.4A)ADP A1211 (-3.4A) | 0.69A | 4urnA-2xcmA:11.9 | 4urnA-2xcmA:23.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zbk | TYPE 2 DNATOPOISOMERASE 6SUBUNIT B (Sulfolobusshibatae) |
PF02518(HATPase_c)PF09239(Topo-VIb_trans) | 5 | ASN B 42SER B 43ASP B 45ASP B 76THR B 170 | RDC B 531 ( 4.1A)RDC B 531 (-3.2A)NoneRDC B 531 (-2.9A)RDC B 531 (-2.5A) | 0.67A | 4urnA-2zbkB:16.1 | 4urnA-2zbkB:17.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3fv5 | DNA TOPOISOMERASE 4SUBUNIT B (Escherichiacoli) |
PF02518(HATPase_c) | 9 | ASN A 42SER A 43ASP A 45GLU A 46ASP A 69ARG A 72ILE A 90ARG A 132THR A 163 | 1EU A 2 (-4.9A)1EU A 2 (-3.0A)None1EU A 2 (-3.4A)1EU A 2 (-3.3A)1EU A 2 (-3.3A)1EU A 2 (-4.5A)1EU A 2 (-3.9A)1EU A 2 (-3.7A) | 0.81A | 4urnA-3fv5A:28.1 | 4urnA-3fv5A:45.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3fv5 | DNA TOPOISOMERASE 4SUBUNIT B (Escherichiacoli) |
PF02518(HATPase_c) | 10 | ASN A 42SER A 43ASP A 45GLU A 46ASP A 69ARG A 72MET A 74PRO A 75ARG A 132THR A 163 | 1EU A 2 (-4.9A)1EU A 2 (-3.0A)None1EU A 2 (-3.4A)1EU A 2 (-3.3A)1EU A 2 (-3.3A)1EU A 2 (-4.4A)1EU A 2 (-4.2A)1EU A 2 (-3.9A)1EU A 2 (-3.7A) | 0.66A | 4urnA-3fv5A:28.1 | 4urnA-3fv5A:45.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3fv5 | DNA TOPOISOMERASE 4SUBUNIT B (Escherichiacoli) |
PF02518(HATPase_c) | 5 | ASP A 45GLU A 46ASP A 69ILE A 116THR A 163 | None1EU A 2 (-3.4A)1EU A 2 (-3.3A)None1EU A 2 (-3.7A) | 1.31A | 4urnA-3fv5A:28.1 | 4urnA-3fv5A:45.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3gbh | NAD(P)H-FLAVINOXIDOREDUCTASE (Staphylococcusepidermidis) |
PF00881(Nitroreductase) | 5 | ASP A 35GLU A 36ILE A 190ARG A 6THR A 152 | None | 1.40A | 4urnA-3gbhA:undetectable | 4urnA-3gbhA:18.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h4l | DNA MISMATCH REPAIRPROTEIN PMS1 (Saccharomycescerevisiae) |
PF01119(DNA_mis_repair)PF13589(HATPase_c_3) | 5 | ASN A 65SER A 66ASP A 68ASP A 90THR A 174 | ANP A 397 ( 2.6A)ANP A 397 ( 4.0A)NoneANP A 397 (-3.6A)ANP A 397 (-3.7A) | 0.27A | 4urnA-3h4lA:16.5 | 4urnA-3h4lA:22.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3la4 | UREASE (Canavaliaensiformis) |
PF00449(Urease_alpha)PF00547(Urease_gamma)PF00699(Urease_beta)PF01979(Amidohydro_1) | 5 | ASP A 633ARG A 639ILE A 615ARG A 646THR A 571 | PO4 A 843 ( 2.5A)NoneNoneNoneNone | 1.36A | 4urnA-3la4A:undetectable | 4urnA-3la4A:14.01 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3lps | TOPOISOMERASE IVSUBUNIT B (Xanthomonasoryzae) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 11 | ASN A 86SER A 87ASP A 89GLU A 90ASP A 113ARG A 116MET A 118PRO A 119ILE A 134ARG A 176THR A 207 | NOV A 901 (-4.0A)NOV A 901 (-3.3A)NOV A 901 ( 4.8A)NOV A 901 (-3.8A)NOV A 901 (-3.5A)NOV A 901 (-3.4A)NOV A 901 (-3.7A)NOV A 901 (-4.5A)NOV A 901 ( 4.9A)NOV A 901 (-2.5A)NOV A 901 ( 4.2A) | 0.69A | 4urnA-3lpsA:27.9 | 4urnA-3lpsA:30.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3o6o | HEAT SHOCK PROTEIN83 (Trypanosomabrucei) |
PF00183(HSP90)PF02518(HATPase_c) | 5 | ASN A 36SER A 37ASP A 39ASP A 78THR A 169 | 94M A 214 (-4.1A)94M A 214 (-3.6A)None94M A 214 (-3.4A)94M A 214 (-3.8A) | 0.37A | 4urnA-3o6oA:11.4 | 4urnA-3o6oA:25.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3o6o | HEAT SHOCK PROTEIN83 (Trypanosomabrucei) |
PF00183(HSP90)PF02518(HATPase_c) | 5 | SER A 37ASP A 39ASP A 78MET A 83THR A 169 | 94M A 214 (-3.6A)None94M A 214 (-3.4A)94M A 214 (-3.4A)94M A 214 (-3.8A) | 0.67A | 4urnA-3o6oA:11.4 | 4urnA-3o6oA:25.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3r92 | HEAT SHOCK PROTEINHSP 90-ALPHA (Homo sapiens) |
PF00183(HSP90)PF02518(HATPase_c) | 5 | ASN A 51SER A 52ASP A 54ASP A 93THR A 184 | 06J A 1 (-4.1A)06J A 1 ( 3.7A)None06J A 1 (-3.5A)06J A 1 (-3.7A) | 0.38A | 4urnA-3r92A:11.7 | 4urnA-3r92A:27.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3r92 | HEAT SHOCK PROTEINHSP 90-ALPHA (Homo sapiens) |
PF00183(HSP90)PF02518(HATPase_c) | 5 | SER A 52ASP A 54ASP A 93MET A 98THR A 184 | 06J A 1 ( 3.7A)None06J A 1 (-3.5A)06J A 1 (-3.7A)06J A 1 (-3.7A) | 0.68A | 4urnA-3r92A:11.7 | 4urnA-3r92A:27.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3u2k | DNA GYRASE SUBUNIT B (Staphylococcusaureus) |
PF02518(HATPase_c) | 9 | ASN A 54SER A 55ASP A 57GLU A 58ASP A 81ARG A 84PRO A 87ARG A 144THR A 173 | 087 A 1 (-3.9A)087 A 1 (-3.3A) MG A 234 ( 4.8A)087 A 1 (-3.4A)087 A 1 (-3.5A)087 A 1 (-3.8A)087 A 1 (-4.3A)087 A 1 (-2.5A)087 A 1 ( 3.8A) | 0.66A | 4urnA-3u2kA:29.6 | 4urnA-3u2kA:50.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3u2k | DNA GYRASE SUBUNIT B (Staphylococcusaureus) |
PF02518(HATPase_c) | 9 | ASN A 54SER A 55GLU A 58ASP A 81ARG A 84PRO A 87ILE A 102ARG A 144THR A 173 | 087 A 1 (-3.9A)087 A 1 (-3.3A)087 A 1 (-3.4A)087 A 1 (-3.5A)087 A 1 (-3.8A)087 A 1 (-4.3A)None087 A 1 (-2.5A)087 A 1 ( 3.8A) | 0.65A | 4urnA-3u2kA:29.6 | 4urnA-3u2kA:50.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3u67 | HEAT SHOCK PROTEIN83-1 (Leishmaniamajor) |
PF00183(HSP90)PF02518(HATPase_c) | 5 | ASN A 36ASP A 39ASP A 78MET A 83THR A 169 | MG A 215 ( 2.5A)NoneADP A 214 (-3.6A)ADP A 214 (-3.5A)ADP A 214 (-3.6A) | 0.75A | 4urnA-3u67A:11.9 | 4urnA-3u67A:22.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3zkb | DNA GYRASE SUBUNIT B (Mycobacteriumtuberculosis) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 6 | ASN A 52ASP A 55GLU A 56ASP A 79ARG A 82PRO A 85 | ANP A 601 ( 2.6A)NoneANP A 601 (-3.9A)ANP A 601 (-3.7A)NoneNone | 0.91A | 4urnA-3zkbA:28.4 | 4urnA-3zkbA:38.34 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3zkb | DNA GYRASE SUBUNIT B (Mycobacteriumtuberculosis) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 6 | ASN A 52ASP A 55GLU A 56ASP A 79PRO A 85ARG A 141 | ANP A 601 ( 2.6A)NoneANP A 601 (-3.9A)ANP A 601 (-3.7A)NoneNone | 0.69A | 4urnA-3zkbA:28.4 | 4urnA-3zkbA:38.34 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) |
PF02518(HATPase_c) | 7 | ASN A 52ASP A 55GLU A 56ASP A 79PRO A 85ARG A 141THR A 169 | B5U A1256 (-3.2A)NoneB5U A1256 (-3.6A)B5U A1256 (-3.5A)B5U A1256 (-4.2A)B5U A1256 ( 4.4A)B5U A1256 (-3.6A) | 0.70A | 4urnA-4b6cA:24.4 | 4urnA-4b6cA:46.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) |
PF02518(HATPase_c) | 7 | ASP A 55GLU A 56ASP A 79ARG A 82PRO A 85ARG A 141THR A 169 | NoneB5U A1256 (-3.6A)B5U A1256 (-3.5A)B5U A1256 (-3.4A)B5U A1256 (-4.2A)B5U A1256 ( 4.4A)B5U A1256 (-3.6A) | 0.86A | 4urnA-4b6cA:24.4 | 4urnA-4b6cA:46.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4e4j | ARGININE DEIMINASE (Mycoplasmapenetrans) |
PF02274(Amidinotransf) | 5 | ASN A 265SER A 59GLU A 60ARG A 439ILE A 364 | None | 1.32A | 4urnA-4e4jA:undetectable | 4urnA-4e4jA:21.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) |
PF02518(HATPase_c) | 8 | ASN A 51ASP A 54GLU A 55ASP A 78ARG A 81MET A 83PRO A 84THR A 172 | 0RA A 301 (-4.7A)None0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)0RA A 301 ( 4.4A)0RA A 301 ( 4.8A)0RA A 301 ( 3.9A) | 0.81A | 4urnA-4em7A:30.8 | 4urnA-4em7A:68.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) |
PF02518(HATPase_c) | 9 | ASN A 51GLU A 55ASP A 78ARG A 81MET A 83PRO A 84ILE A 98ARG A 140THR A 172 | 0RA A 301 (-4.7A)0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)0RA A 301 ( 4.4A)0RA A 301 ( 4.8A)None0RA A 301 (-2.5A)0RA A 301 ( 3.9A) | 0.92A | 4urnA-4em7A:30.8 | 4urnA-4em7A:68.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gqt | HEAT SHOCK PROTEIN90 (Caenorhabditiselegans) |
PF00183(HSP90)PF02518(HATPase_c) | 5 | ASN A 39ASP A 42ASP A 81MET A 86THR A 172 | ZN A 501 ( 2.5A)NoneADP A 500 (-3.7A)ADP A 500 (-3.4A)ADP A 500 (-3.7A) | 0.79A | 4urnA-4gqtA:12.0 | 4urnA-4gqtA:26.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hxw | DNA GYRASE SUBUNIT B (Enterococcusfaecalis) |
PF02518(HATPase_c) | 8 | ASN A 55SER A 56ASP A 58GLU A 59ASP A 82ARG A 85PRO A 88THR A 174 | 1A0 A 301 (-3.8A)1A0 A 301 (-3.3A)None1A0 A 301 (-3.2A)1A0 A 301 (-3.4A)1A0 A 301 (-3.5A)1A0 A 301 (-4.2A)1A0 A 301 (-3.6A) | 0.35A | 4urnA-4hxwA:31.0 | 4urnA-4hxwA:55.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hym | TOPOISOMERASE IV,SUBUNIT B (Francisellatularensis) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 8 | ASN A 41SER A 42ASP A 44ASP A 68MET A 73ILE A 89ARG A 131THR A 162 | CJC A 401 (-4.0A)CJC A 401 (-3.1A)NoneCJC A 401 (-3.3A)CJC A 401 (-3.3A)CJC A 401 (-4.6A)CJC A 401 (-4.2A)CJC A 401 (-3.6A) | 0.80A | 4urnA-4hymA:27.5 | 4urnA-4hymA:31.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hym | TOPOISOMERASE IV,SUBUNIT B (Francisellatularensis) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 8 | ASN A 41SER A 42ASP A 44ASP A 68MET A 73PRO A 74ARG A 131THR A 162 | CJC A 401 (-4.0A)CJC A 401 (-3.1A)NoneCJC A 401 (-3.3A)CJC A 401 (-3.3A)CJC A 401 ( 4.7A)CJC A 401 (-4.2A)CJC A 401 (-3.6A) | 0.83A | 4urnA-4hymA:27.5 | 4urnA-4hymA:31.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hym | TOPOISOMERASE IV,SUBUNIT B (Francisellatularensis) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 9 | ASN A 41SER A 42GLU A 45ASP A 68ARG A 71MET A 73ILE A 89ARG A 131THR A 162 | CJC A 401 (-4.0A)CJC A 401 (-3.1A)CJC A 401 (-3.3A)CJC A 401 (-3.3A)CJC A 401 ( 4.0A)CJC A 401 (-3.3A)CJC A 401 (-4.6A)CJC A 401 (-4.2A)CJC A 401 (-3.6A) | 0.66A | 4urnA-4hymA:27.5 | 4urnA-4hymA:31.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hym | TOPOISOMERASE IV,SUBUNIT B (Francisellatularensis) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 9 | ASN A 41SER A 42GLU A 45ASP A 68ARG A 71MET A 73PRO A 74ARG A 131THR A 162 | CJC A 401 (-4.0A)CJC A 401 (-3.1A)CJC A 401 (-3.3A)CJC A 401 (-3.3A)CJC A 401 ( 4.0A)CJC A 401 (-3.3A)CJC A 401 ( 4.7A)CJC A 401 (-4.2A)CJC A 401 (-3.6A) | 0.66A | 4urnA-4hymA:27.5 | 4urnA-4hymA:31.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hym | TOPOISOMERASE IV,SUBUNIT B (Francisellatularensis) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 5 | SER A 42GLU A 45ASP A 68ARG A 71ILE A 86 | CJC A 401 (-3.1A)CJC A 401 (-3.3A)CJC A 401 (-3.3A)CJC A 401 ( 4.0A)None | 0.92A | 4urnA-4hymA:27.5 | 4urnA-4hymA:31.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) |
PF02518(HATPase_c) | 7 | ASN A 49ASP A 52ASP A 76MET A 81PRO A 82ARG A 138THR A 169 | 19Y A 301 (-3.8A)None19Y A 301 (-3.3A)19Y A 301 (-3.7A)19Y A 301 (-4.0A)19Y A 301 ( 4.8A)19Y A 301 (-3.7A) | 0.63A | 4urnA-4hz5A:30.9 | 4urnA-4hz5A:67.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) |
PF02518(HATPase_c) | 7 | ASN A 49ASP A 52ASP A 76PRO A 82ILE A 96ARG A 138THR A 169 | 19Y A 301 (-3.8A)None19Y A 301 (-3.3A)19Y A 301 (-4.0A)19Y A 301 ( 4.7A)19Y A 301 ( 4.8A)19Y A 301 (-3.7A) | 0.72A | 4urnA-4hz5A:30.9 | 4urnA-4hz5A:67.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) |
PF02518(HATPase_c) | 8 | ASN A 49GLU A 53ASP A 76ARG A 79MET A 81PRO A 82ARG A 138THR A 169 | 19Y A 301 (-3.8A)19Y A 301 (-3.3A)19Y A 301 (-3.3A)19Y A 301 (-4.0A)19Y A 301 (-3.7A)19Y A 301 (-4.0A)19Y A 301 ( 4.8A)19Y A 301 (-3.7A) | 0.59A | 4urnA-4hz5A:30.9 | 4urnA-4hz5A:67.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) |
PF02518(HATPase_c) | 8 | ASN A 49GLU A 53ASP A 76ARG A 79PRO A 82ILE A 96ARG A 138THR A 169 | 19Y A 301 (-3.8A)19Y A 301 (-3.3A)19Y A 301 (-3.3A)19Y A 301 (-4.0A)19Y A 301 (-4.0A)19Y A 301 ( 4.7A)19Y A 301 ( 4.8A)19Y A 301 (-3.7A) | 0.64A | 4urnA-4hz5A:30.9 | 4urnA-4hz5A:67.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4j8s | CCR4-NOTTRANSCRIPTIONCOMPLEX SUBUNIT 1 (Homo sapiens) |
PF16417(CNOT1_TTP_bind) | 5 | ASN A 839SER A 840ASP A 836GLU A 837ARG A 873 | None | 1.32A | 4urnA-4j8sA:undetectable | 4urnA-4j8sA:19.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ja0 | PHOSPHORIBOSYLAMINOIMIDAZOLE CARBOXYLASE (Bombyx mori) |
PF00731(AIRC)PF01259(SAICAR_synt) | 5 | SER A 144GLU A 145ARG A 169ILE A 160THR A 131 | SO4 A 502 (-4.6A)SO4 A 502 (-4.3A)NoneNoneNone | 1.46A | 4urnA-4ja0A:undetectable | 4urnA-4ja0A:18.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4k7c | AMINOPEPTIDASE C (Lactobacillusrhamnosus) |
PF03051(Peptidase_C1_2) | 5 | ASN A 41SER A 44ASP A 43ASP A 333THR A 334 | GOL A 503 (-4.4A)NoneGOL A 503 (-2.9A)NoneNone | 1.35A | 4urnA-4k7cA:undetectable | 4urnA-4k7cA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4umv | ZINC-TRANSPORTINGATPASE (Shigella sonnei) |
PF00122(E1-E2_ATPase)PF00702(Hydrolase) | 5 | SER A 285GLU A 284ASP A 283ARG A 296ILE A 326 | None | 1.37A | 4urnA-4umvA:undetectable | 4urnA-4umvA:15.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4url | DNA TOPOISOMERASEIV, B SUBUNIT (Staphylococcusaureus) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 10 | ASN A 49SER A 50ASP A 52GLU A 53ASP A 76ARG A 79MET A 81PRO A 82ILE A 96THR A 168 | XAM A2000 (-3.9A)XAM A2000 (-3.4A)NoneXAM A2000 (-3.1A)XAM A2000 (-3.6A)XAM A2000 (-3.7A)XAM A2000 (-4.3A)XAM A2000 (-4.8A)NoneXAM A2000 (-3.6A) | 0.76A | 4urnA-4urlA:32.8 | 4urnA-4urlA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4url | DNA TOPOISOMERASEIV, B SUBUNIT (Staphylococcusaureus) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 10 | ASN A 49SER A 50ASP A 52GLU A 53ASP A 76MET A 81PRO A 82ILE A 96ARG A 138THR A 168 | XAM A2000 (-3.9A)XAM A2000 (-3.4A)NoneXAM A2000 (-3.1A)XAM A2000 (-3.6A)XAM A2000 (-4.3A)XAM A2000 (-4.8A)NoneNoneXAM A2000 (-3.6A) | 0.79A | 4urnA-4urlA:32.8 | 4urnA-4urlA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4urm | DNA GYRASE SUBUNIT B (Staphylococcusaureus) |
PF02518(HATPase_c) | 10 | ASN A 54SER A 55ASP A 57GLU A 58ASP A 81ARG A 84PRO A 87ILE A 102ARG A 144THR A 173 | XAM A2000 (-3.7A)XAM A2000 (-3.3A)NoneXAM A2000 (-2.6A)XAM A2000 (-3.4A)XAM A2000 (-3.6A)XAM A2000 ( 4.9A)XAM A2000 (-4.5A)NoneXAM A2000 (-3.8A) | 0.60A | 4urnA-4urmA:30.3 | 4urnA-4urmA:58.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4x9l | HEAT SHOCK PROTEIN (Oryza sativa) |
PF00183(HSP90)PF02518(HATPase_c) | 5 | ASN A 39SER A 40ASP A 42ASP A 81THR A 173 | ACP A 301 (-2.7A)ACP A 301 ( 3.7A)NoneACP A 301 (-3.9A)ACP A 301 (-3.8A) | 0.50A | 4urnA-4x9lA:12.7 | 4urnA-4x9lA:25.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4x9l | HEAT SHOCK PROTEIN (Oryza sativa) |
PF00183(HSP90)PF02518(HATPase_c) | 5 | SER A 40ASP A 42ASP A 81MET A 86THR A 173 | ACP A 301 ( 3.7A)NoneACP A 301 (-3.9A)ACP A 301 (-3.4A)ACP A 301 (-3.8A) | 0.84A | 4urnA-4x9lA:12.7 | 4urnA-4x9lA:25.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4y0a | SHIKIMATE KINASE (Acinetobacterbaumannii) |
PF01202(SKI) | 5 | SER A 49GLU A 52ASP A 48ARG A 55ILE A 64 | None | 1.29A | 4urnA-4y0aA:undetectable | 4urnA-4y0aA:20.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4zvi | DNA GYRASE SUBUNIT B (Escherichiacoli) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 9 | ASN A 46ASP A 49GLU A 50ASP A 73ARG A 76PRO A 79ILE A 94ARG A 136THR A 165 | 4S4 A 401 (-4.3A)None4S4 A 401 (-3.1A)4S4 A 401 (-3.4A)4S4 A 401 (-2.8A)4S4 A 401 (-4.5A)NoneNone4S4 A 401 ( 3.8A) | 0.58A | 4urnA-4zviA:30.1 | 4urnA-4zviA:39.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5b04 | TRANSLATIONINITIATION FACTOREIF-2B SUBUNIT ALPHA (Schizosaccharomycespombe) |
PF01008(IF-2B) | 5 | SER A 246GLU A 245ASP A 322ARG A 122ILE A 40 | NonePO4 A 401 ( 4.3A)NoneNoneNone | 1.13A | 4urnA-5b04A:undetectable | 4urnA-5b04A:18.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5j5p | DNA TOPOISOMERASE 4SUBUNIT B (Streptococcuspneumoniae) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 9 | ASN A 51ASP A 54GLU A 55ASP A 78ARG A 81MET A 83PRO A 84ARG A 140THR A 172 | MG A 503 ( 2.5A)NoneANP A 501 (-3.2A)ANP A 501 (-2.6A)NoneANP A 501 (-4.7A)NoneNoneANP A 501 (-3.5A) | 0.92A | 4urnA-5j5pA:30.3 | 4urnA-5j5pA:40.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5j5p | DNA TOPOISOMERASE 4SUBUNIT B (Streptococcuspneumoniae) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 8 | ASN A 51ASP A 54GLU A 55ASP A 78ARG A 81PRO A 84ILE A 98THR A 172 | MG A 503 ( 2.5A)NoneANP A 501 (-3.2A)ANP A 501 (-2.6A)NoneNoneANP A 501 ( 3.4A)ANP A 501 (-3.5A) | 1.11A | 4urnA-5j5pA:30.3 | 4urnA-5j5pA:40.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ngy | DSR-M GLUCANSUCRASEINACTIVE MUTANTE715Q (Leuconostoccitreum) |
no annotation | 5 | ASN A 720SER A 718ASP A 680ILE A 612THR A 603 | None | 1.41A | 4urnA-5ngyA:undetectable | 4urnA-5ngyA:10.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ofb | MORC FAMILY CW-TYPEZINC FINGER PROTEIN2 (Homo sapiens) |
no annotation | 5 | ASN B 39ASP B 42ASP B 68MET B 73THR B 197 | MG B 703 ( 2.7A)NoneATP B 702 (-3.4A)ATP B 702 (-3.6A)ATP B 702 (-3.7A) | 0.81A | 4urnA-5ofbB:11.4 | 4urnA-5ofbB:13.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x9y | DNA MISMATCH REPAIRPROTEIN MUTL (Aquifexaeolicus) |
no annotation | 5 | ASN C 26SER C 27ASP C 29ASP C 51THR C 135 | None | 0.72A | 4urnA-5x9yC:15.2 | 4urnA-5x9yC:21.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xz3 | PEPTIDOGLYCAN-RECOGNITION PROTEIN (Apis mellifera) |
no annotation | 5 | ASN A 53SER A 52GLU A 55ARG A 58ARG A 13 | None | 1.42A | 4urnA-5xz3A:undetectable | 4urnA-5xz3A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6bnp | UNCONVENTIONALMYOSIN-VI (Sus scrofa) |
no annotation | 5 | ASN I 62ASP I 61GLU I 60ASP I 58ILE I 95 | None | 1.46A | 4urnA-6bnpI:undetectable | 4urnA-6bnpI:20.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6fc3 | EUKARYOTICTRANSLATIONINITIATION FACTOR 4E (Saccharomycescerevisiae) |
no annotation | 5 | ASP A 171GLU A 170PRO A 198ILE A 211THR A 167 | None | 0.92A | 4urnA-6fc3A:undetectable | 4urnA-6fc3A:17.20 |